Literature DB >> 19841529

Incidence of end-stage renal disease in Guilan Province, Iran, 2005 to 2007.

Ali Monfared1, Afshin Safaei, Zahra Panahandeh, Leila Nemati.   

Abstract

We reviewed records of patients with ESRD in all dialysis and kidney transplant centers of Guilan province to determine the incidence and modalities for treatment of ESRD from 2005 to 2007. Records of 759 patients were reviewed during the 3-year period of the study. The male-female ratio was 1.34:1 and the men age at the time of diagnosis was 56.3 +/- 16.8 years. The most frequent age group was 60 years and older (45.8%). The incidence ESRD during 2005, 2006, and 2007 were 100.36 pmp, 100.60 pmp, and 110.66 pmp, respectively. The most common causes of ESRD were hypertension (29.4%), unknown (26.6%), and diabetes mellitus (17.9%). The most common modality at initiation of renal replacement therapy was hemodialysis (96.0%). The entrance rate of hemodialysis in 2005, 2006, and 2007 were 29.6%, 35.0%, and 35.4%, and the discontinuing rate of hemodialysis in these years were 29.5%, 32.1%, and 38.4%, respectively.

Entities:  

Mesh:

Year:  2009        PMID: 19841529

Source DB:  PubMed          Journal:  Iran J Kidney Dis        ISSN: 1735-8582            Impact factor:   0.892


  4 in total

1.  Management and outcome of children with end-stage renal disease in northwest Iran.

Authors:  F Mortazavi; M Maleki
Journal:  Indian J Nephrol       Date:  2012-03

2.  Estimation of the prevalence of chronic kidney disease: The results of a model based estimation in Kerman, Iran.

Authors:  Reza Tabrizi; Farzaneh Zolala; Maryam Nasirian; Mohammad Reza Baneshi; Abbas Etminan; Eghbal Sekhavati; Mahmoud Khodadost; Ali Akbar Haghdoost
Journal:  Med J Islam Repub Iran       Date:  2016-03-05

3.  The Effect of Stress Management Training on Hope in Hemodialysis Patients.

Authors:  Farzad Poorgholami; Sareh Abdollahifard; Marzieh Zamani; Marzieh Kargar Jahromi; Zohreh Badiyepeyma Jahromi
Journal:  Glob J Health Sci       Date:  2015-11-18

4.  Etiology of Renal Replacement Therapy in Iran.

Authors:  Negar Morovatdar; Gholamreza Tayebi Nasrabad; Konstantinos Tsarouhas; Ramin Rezaee
Journal:  Int J Nephrol       Date:  2019-11-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.